Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Sedation in Cataract Surgery
NCT07325227Phase 4Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in cataract. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
cataract
Beyond the preview
Go deeper on NCT07325227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07325227.